SCHEMBL4897738

SCHEMBL4897738

CCCC(=O)c1cccc(OC(CC)C(=O)O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.52
PPARG P37231 5/20 0.49
PPARA Q07869 4/20 0.49
FOLH1 Q04609 1/20 0.49
KMT2A Q03164 1/20 0.46
THRA P10827 1/20 0.45
THRB P10828 1/20 0.45
HPGD P15428 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
DRD1 P21728 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
ADRA1A P35348 1/20 0.42
OPRM1 P35372 1/20 0.42
DRD3 P35462 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KCNH2 Q12809 1/20 0.42
FABP4 P15090 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895944 0.88 SMN1; SMN2 (0.55) SMN1; SMN2PPARGPPARAFOLH1KMT2A
SCHEMBL5010216 0.84 SMN1; SMN2 (0.56) SMN1; SMN2PPARGPPARAHPGDL3MBTL1
SCHEMBL2556069 0.84 SMN1; SMN2 (0.56) SMN1; SMN2PPARGPPARAFOLH1KMT2A
SCHEMBL30530857 0.81 SMN1; SMN2 (0.54) SMN1; SMN2PPARGPPARAFOLH1KMT2A
SCHEMBL7117920 0.81 PRSS1 (0.55) SMN1; SMN2PPARGPPARA
SCHEMBL19707956 0.81 PDE4A (0.51) SMN1; SMN2KMT2ATHRATHRB
SCHEMBL15199284 0.80 FOLH1 (0.56) PPARGPPARAFOLH1THRATHRB
SCHEMBL4891913 0.80 ESR1 (0.56) SMN1; SMN2PPARGPPARAFOLH1
SCHEMBL11463053 0.79 ERCC5 (0.63) SMN1; SMN2KMT2ATHRATHRBHPGD
SCHEMBL4637827 0.79 CES2 (0.62) SMN1; SMN2KMT2AHPGDHTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255078-A1 Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators KATAMREDDY SUBBA REDDY 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255078-A1 Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators GPER1, ESR2, ESRRG SMN1; SMN2 4741/4885PPARG 63/4885PPARA 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.